Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aionx’s cleanSURFACES® mats have demonstrated significant reduction of pathogens on high-touch surfaces in healthcare settings. In a 30-day VA hospital trial, 17 out of 18 common HAI-causing pathogens were eliminated from tested surfaces after use of the mats.[1] The technology is supported by third-party studies and was developed with Department of Defense collaboration for COVID emergency response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aionx Antimicrobial Technologies.